Development of extramedullary sites of leukaemia during ruxolitinib therapy for myelofibrosis Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Neoplasms, Second Primary
  • Primary Myelofibrosis
  • Protein Kinase Inhibitors
  • Pyrazoles
  • Sarcoma, Myeloid

publication date

  • January 2014

Research

keywords

  • Article

Identity

Digital Object Identifier (DOI)

  • 10.1111/bjh.12948

Additional Document Info

start page

  • 144

end page

  • 6

volume

  • 167

number

  • 1